CD30 is a transmembrane protein receptor of the tumor necrosis factor (TNF) family, and it is normally expressed in activated T cells.97, 98 CD30 protein targeting appears to be an attractive and rational approach for the diagnosis and treatment of ALCL. Here, TNFRSF8 is linked to anaplastic large cell lymphoma.